The efficacy of autologous Platelet-Rich Plasma (PRP) for the adjuvant treatment of Frontal Fibrosing Alopecia (FFA), a randomized, controlled trial, split-scalp study

Status

Unknown

Phases

Phase 1Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20231021001

Enrollment

Registered

2023-10-21

Start date

2023-11-30

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontal Fibrosing Alopecia Frontal Fibrosing Alopecia FFA

Interventions

PRP was extracted with the in-house protocol using a centrifuge machine (Eppendorf 5804R, Germany). Whole blood was drawn by venipuncture into a syringe containing an anticoagulant citrate dextrose so

Experimental Other,Experimental Other

PRP side,control side

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The subject is aged > 18 years 2. FFA patient who has active disease 3. Subjects who can comply with trial procedures and are available for the duration of follow-up

Exclusion criteria

Exclusion criteria: 1. pregnancy of breast feeding patient 2. Subjects who has abnormal coagulation 3. Subjects who can not comply with trial procedures and are available for the duration of follow-up

Design outcomes

Primary

Measure	Time frame
sign of inflammation 9 months grading sign of inflammation	—

Secondary

Measure	Time frame
hair density 9 months hair count/cm2,hairline recession 9 months centimeter,patient satisfaction 9 months score	—

Countries

Thailand

Contacts

Public ContactRatchathorn Panchaprateep

Faculty of Medicine, Chulalongkorn University

rpanchaprateep@gmail.com0898923819

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026